Publications | Centre for Tuberculosis Research

Publications from researchers involved with the Centre for Tuberculosis Research at KI.

2019

Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial.
Ashenafi S, Amogne W, Kassa E, Gebreselassie N, Bekele A, Aseffa G, et al
Nutrients 2019 Jan;11(1):

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study.
Wikell A, Åberg H, Shedrawy J, Röhl I, Jonsson J, Berggren I, et al
BMC Public Health 2019 Feb;19(1):151

Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
Pedrazzoli D, Borghi J, Viney K, Houben RMGJ, Lönnroth K
Int. J. Tuberc. Lung Dis. 2019 01;23(1):5-11

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.
Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, et al
Int. J. Infect. Dis. 2019 Mar;80S():S45-S49

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.
Rachow A, Ivanova O, Wallis R, Charalambous S, Jani I, Bhatt N, et al
BMC Pulm Med 2019 Jan;19(1):4

2018

Evolution of Programmatic Definitions Used in Tuberculosis Prevention and Care.
Migliori GB,
Clin. Infect. Dis. 2019 May;68(10):1787-1789

Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.
Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, et al
Eur. Respir. J. 2018 12;52(6):

Defining a migrant-inclusive tuberculosis research agenda to end TB.
Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, et al
Int. J. Tuberc. Lung Dis. 2018 08;22(8):835-843

Measuring catastrophic costs due to tuberculosis in Viet Nam.
Nhung NV, Hoa NB, Anh NT, Anh LTN, Siroka A, Lönnroth K, et al
Int. J. Tuberc. Lung Dis. 2018 09;22(9):983-990

Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lönnroth K, Shaweno D, et al
J. Infect. 2018 11;77(5):357-367

Smear Microscopy for Diagnosis of Pulmonary Tuberculosis in Eastern Sudan.
Shuaib YA, Khalil EAG, Schaible UE, Wieler LH, Bakheit MAM, Mohamed-Noor SE, et al
Tuberc Res Treat 2018 ;2018():8038137

Uptake of governmental social protection and financial hardship during drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil.
Rudgard WE, das Chagas NS, Gayoso R, Barreto ML, Boccia D, Smeeth L, et al
Eur. Respir. J. 2018 03;51(3):

Modelling the impact of social protection on tuberculosis: the S-PROTECT project.
Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, et al
BMC Public Health 2018 06;18(1):786

'Valuable but incomplete!' A qualitative study about migrants' perspective on health examinations in Stockholm.
Shedrawy J, Lönnroth K, Kulane A
Int Health 2018 05;10(3):191-196

Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
Chihota VN, Niehaus A, Streicher EM, Wang X, Sampson SL, Mason P, et al
PLoS ONE 2018 ;13(8):e0200632

Vitamin D₃ Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis.
Ashenafi S, Mazurek J, Rehn A, Lemma B, Aderaye G, Bekele A, et al
Nutrients 2018 Jun;10(6):

Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia.
Bekele A, Gebreselassie N, Ashenafi S, Kassa E, Aseffa G, Amogne W, et al
J. Intern. Med. 2018 09;284(3):292-306

Friends and foes of tuberculosis: modulation of protective immunity.
Brighenti S, Joosten SA
J. Intern. Med. 2018 May;():

Vitamin D and tuberculosis: where next?
Brighenti S, Bergman P, Martineau AR
J. Intern. Med. 2018 May;():

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, et al
J. Intern. Med. 2018 May;():

Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection.
Wan M, Tang X, Rekha RS, Muvva SSVJR, Brighenti S, Agerberth B, et al
FASEB J. 2018 05;32(5):2827-2840

Genetic diversity and potential routes of transmission of Mycobacterium bovis in Mozambique.
Machado A, Rito T, Ghebremichael S, Muhate N, Maxhuza G, Macuamule C, et al
PLoS Negl Trop Dis 2018 01;12(1):e0006147

Addressing social determinants to end tuberculosis.
Wingfield T, Tovar MA, Datta S, Saunders MJ, Evans CA
Lancet 2018 03;391(10126):1129-1132

Uptake of governmental social protection and financial hardship during drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil.
Rudgard WE, das Chagas NS, Gayoso R, Barreto ML, Boccia D, Smeeth L, et al
Eur. Respir. J. 2018 03;51(3):

Modelling the impact of social protection on tuberculosis: the S-PROTECT project.
Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, et al
BMC Public Health 2018 06;18(1):786

The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1.
Carter DJ, Glaziou P, Lönnroth K, Siroka A, Floyd K, Weil D, et al
Lancet Glob Health 2018 05;6(5):e514-e522

Association of Obesity, Diabetes, and Risk of Tuberculosis: Two Population-Based Cohorts.
Lin HH, Wu CY, Wang CH, Fu H, Lönnroth K, Chang YC, et al
Clin. Infect. Dis. 2018 02;66(5):699-705

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.
Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, et al
Lancet Infect Dis 2018 06;18(6):675-683

Detection of Mycobacterium tuberculosis pncA Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional Sequencing.
Willby MJ, Wijkander M, Havumaki J, Johnson K, Werngren J, Hoffner S, et al
Antimicrob. Agents Chemother. 2018 01;62(1):

Drug-resistant Mycobacterium tuberculosis: Epidemiology and role of morphological alterations.
Velayati AA, Farnia P, Hoffner S
J Glob Antimicrob Resist 2018 03;12():192-196

Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group.
Ohene SA, Bonsu F, Hanson-Nortey NN, Toonstra A, Sackey A, Lonnroth K, et al
BMC Infect. Dis. 2017 12;17(1):739

2017

Tuberculosis, social determinants and co-morbidities (including HIV).
Duarte R, Lönnroth K, Carvalho C, Lima F, Carvalho ACC, Muñoz-Torrico M, et al
Pulmonology ;24(2):115-119

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, et al
Lancet Glob Health 2017 11;5(11):e1123-e1132

Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, et al
PLoS Med. 2017 Nov;14(11):e1002418

Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
Pedrazzoli D, Boccia D, Dodd PJ, Lönnroth K, Dowdy DW, Siroka A, et al
Int. J. Tuberc. Lung Dis. 2017 09;21(9):957-964

Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, et al
Int. J. Tuberc. Lung Dis. 2017 06;21(6):624-637

Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease.
Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J
Eur. Respir. J. 2017 07;50(1):

Radiological screening of refugees in Germany.
Herzmann C, Golakov M, Malekzada F, Lonnroth K, Kranzer K
Eur. Respir. J. 2017 05;49(5):

Methodological considerations for economic modelling of latent tuberculous infection screening in migrants.
Shedrawy J, Siroka A, Oxlade O, Matteelli A, Lönnroth K
Int. J. Tuberc. Lung Dis. 2017 09;21(9):977-989

Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning 'Multidrug-resistant tuberculosis and migration to Europe'.
Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, et al
Clin. Microbiol. Infect. 2017 08;23(8):580

The long and winding road of chest radiography for tuberculosis detection.
Miller C, Lonnroth K, Sotgiu G, Migliori GB
Eur. Respir. J. 2017 05;49(5):

[Differential diagnosis of osteomyelitis of the calcaneus].
Khuri S, Ochsner PE
Z Orthop Ihre Grenzgeb ;124(1):19-21

Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
Kunst H, Burman M, Arnesen TM, Fiebig L, Hergens MP, Kalkouni O, et al
Int. J. Tuberc. Lung Dis. 2017 08;21(8):840-851

Post-2015, why delay to seek healthcare? Perceptions and field experiences from TB healthcare providers in northern Malawi: a qualitative study.
Chimbatata NBW, Zhou CM, Chimbatata CM, Xu B
Infect Dis Poverty 2017 May;6(1):60

Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China.
Yuan L, Zhang H, Zhou C, Jiang W, Zhao Q, Biao X
BMC Infect. Dis. 2017 01;17(1):71

Discovery of susceptibility loci associated with tuberculosis in Han Chinese.
Qi H, Zhang YB, Sun L, Chen C, Xu B, Xu F, et al
Hum. Mol. Genet. 2017 12;26(23):4752-4763

High prevalence of TB disease in contacts of adults with extrapulmonary TB.
Wingfield T, MacPherson P, Cleary P, Ormerod LP
Thorax 2018 08;73(8):785-787

Quantifying the need for enhanced case management for TB patients as part of TB cohort audit in the North West of England: a descriptive study.
Tucker A, Mithoo J, Cleary P, Woodhead M, MacPherson P, Wingfield T, et al
BMC Public Health 2017 11;17(1):881

Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, et al
PLoS Med. 2017 Nov;14(11):e1002418

Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
Pedrazzoli D, Boccia D, Dodd PJ, Lönnroth K, Dowdy DW, Siroka A, et al
Int. J. Tuberc. Lung Dis. 2017 09;21(9):957-964

A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study.
Saunders MJ, Wingfield T, Tovar MA, Baldwin MR, Datta S, Zevallos K, et al
Lancet Infect Dis 2017 11;17(11):1190-1199

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE, et al
Nat. Genet. 2017 Mar;49(3):395-402Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015.
Mansjo M, Werngren J, Hoffner S
Int J Mycobacteriol ;6(2):156-161

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.
Anthony RM, Cynamon M, Hoffner S, Werngren J, den Hertog AL, van Soolingen D
Antimicrob. Agents Chemother. 2017 06;61(6):

Mycobacterium tuberculosis of the Beijing Genotype in Iran and the World Health Organization Eastern Mediterranean Region: A Meta-Analysis.
Hoffner S, Sahebi L, Ansarin K, Sabour S, Mohajeri P
Microb. Drug Resist. ;24(6):693-698

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, et al
Eur. Respir. J. 2017 12;50(6):

Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis.
Brunner K, Steiner EM, Reshma RS, Sriram D, Schnell R, Schneider G
Bioorg. Med. Chem. Lett. 2017 10;27(19):4582-4587

Binding and processing of β-lactam antibiotics by the transpeptidase LdtMt2 from Mycobacterium tuberculosis.
Steiner EM, Schneider G, Schnell R
FEBS J. 2017 03;284(5):725-741